The standard industry response to a patent cliff is lifecycle management: launch a successor product, file secondary patents on the original, shift prescribing, and delay the effective date of generic competition
This phenomenon is well-documented in weight loss research, regardless of the method used to achieve weight reduction
Richard Besser, about Plexus
NICE guidance (NG49) on NAFLD management emphasises lifestyle modification as the cornerstone of treatment, with weight loss of 710% recommended to achieve histological improvement
Most compounding pharmacies do not pursue them, which makes Strive one of the more transparent operations in the compounding space
Nature PubMed Preclinical literature and narrative reviews describe pleiotropic actions including angiogenesis modulation (promotion in healing contexts and proposed inhibition in rodent corneal neovascularization models) and purported cytoprotective effects across diverse injury paradigms, but these remain unconfirmed in controlled human experiments